Speaker illustration

Doctor Caroline Holm Noergaard

Aalborg University Hospital, Aalborg (Denmark)

SGLT-2 inhibitors versus GLP-1 receptor agonists and risk of mortality, chronic kidney disease and hospitalisation for heart failure in patients with type 2 diabetes

Event: ESC CONGRESS 2019

Topic: Antidiabetic Pharmacotherapy

Session: New frontiers: SGLT2 inhibitors in cardiorenal disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk